The pahtway p1427 has 51 genes in the original annotation. Currently, there are 35 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
27250 | PDCD4 | H731 | programmed cell death 4 (neoplastic transformation inhibitor) | | | 10q24 |
7351 | UCP2 | BMIQ4 | SLC25A8 | UCPH | uncoupling protein 2 (mitochondrial, proton carrier) | | | 11q13 |
3312 | HSPA8 | HEL-33 | HEL-S-72p | HSC54 | HSC70 | HSC71 | HSP71 | HSP73 | HSPA10 | LAP-1 | LAP1 | NIP71 | heat shock protein family A (Hsp70) member 8 | | | 11q24.1 |
5037 | PEBP1 | HCNP | HCNPpp | HEL-210 | HEL-S-34 | HEL-S-96 | PBP | PEBP | PEBP-1 | RKIP | phosphatidylethanolamine binding protein 1 | | | 12q24.23 |
9761 | MLEC | KIAA0152 | malectin | | | 12q24.31 |
51433 | ANAPC5 | APC5 | anaphase promoting complex subunit 5 | | | 12q24.31 |
10301 | DLEU1 | BCMS | BCMS1 | DLB1 | DLEU2 | LEU1 | LEU2 | LINC00021 | NCRNA00021 | XTP6 | deleted in lymphocytic leukemia 1 (non-protein coding) | | | 13q14.3 |
1033 | CDKN3 | CDI1 | CIP2 | KAP | KAP1 | cyclin-dependent kinase inhibitor 3 | | | 14q22 |
1201 | CLN3 | BTS | JNCL | ceroid-lipofuscinosis, neuronal 3 | | | 16p12.1 |
79006 | METRN | C16orf23 | c380A1.2 | meteorin, glial cell differentiation regulator | | | 16p13.3 |
409 | ARRB2 | ARB2 | ARR2 | BARR2 | arrestin, beta 2 | | | 17p13 |
2063 | NR2F6 | EAR-2 | EAR2 | ERBAL2 | nuclear receptor subfamily 2 group F member 6 | | | 19p13.1 |
5725 | PTBP1 | HNRNP-I | HNRNPI | HNRPI | PTB | PTB-1 | PTB-T | PTB2 | PTB3 | PTB4 | pPTB | polypyrimidine tract binding protein 1 | | | 19p13.3 |
5605 | MAP2K2 | CFC4 | MAPKK2 | MEK2 | MKK2 | PRKMK2 | mitogen-activated protein kinase kinase 2 | | | 19p13.3 |
513 | ATP5D | - | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit | | | 19p13.3 |
6183 | MRPS12 | MPR-S12 | MT-RPS12 | RPMS12 | RPS12 | RPSM12 | mitochondrial ribosomal protein S12 | | | 19q13.1-q13.2 |
5424 | POLD1 | CDC2 | CRCS10 | MDPL | POLD | polymerase (DNA) delta 1, catalytic subunit | | | 19q13.3 |
11332 | ACOT7 | ACH1 | ACT | BACH | CTE-II | LACH | LACH1 | hBACH | acyl-CoA thioesterase 7 | | | 1p36 |
8751 | ADAM15 | MDC15 | ADAM metallopeptidase domain 15 | | | 1q21.3 |
2752 | GLUL | GLNS | GS | PIG43 | PIG59 | glutamate-ammonia ligase | | | 1q31 |
142 | PARP1 | ADPRT | ADPRT 1 | ADPRT1 | ARTD1 | PARP | PARP-1 | PPOL | pADPRT-1 | poly(ADP-ribose) polymerase 1 | | | 1q41-q42 |
3785 | KCNQ2 | BFNC | BFNS1 | EBN | EBN1 | EIEE7 | ENB1 | HNSPC | KCNA11 | KV7.2 | KVEBN1 | potassium voltage-gated channel subfamily Q member 2 | | | 20q13.3 |
2202 | EFEMP1 | DHRD | DRAD | FBLN3 | FBNL | FIBL-3 | MLVT | MTLV | S1-5 | EGF containing fibulin-like extracellular matrix protein 1 | | | 2p16 |
51011 | FAHD2A | CGI-105 | fumarylacetoacetate hydrolase domain containing 2A | | | 2q11.2 |
274 | BIN1 | AMPH2 | AMPHL | SH3P9 | bridging integrator 1 | | | 2q14 |
5757 | PTMA | TMSA | prothymosin, alpha | | | 2q37.1 |
6502 | SKP2 | FBL1 | FBXL1 | FLB1 | p45 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase | | | 5p13 |
10949 | HNRNPA0 | HNRPA0 | heterogeneous nuclear ribonucleoprotein A0 | | | 5q31 |
821 | CANX | CNX | IP90 | P90 | calnexin | | | 5q35 |
28978 | TMEM14A | C6orf73 | PTD011 | transmembrane protein 14A | | | 6p12.2 |
57819 | LSM2 | C6orf28 | G7B | YBL026W | snRNP | LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated | | | 6p21.3 |
23089 | PEG10 | EDR | HB-1 | MEF3L | Mar2 | Mart2 | RGAG3 | paternally expressed 10 | | | 7q21 |
800 | CALD1 | CDM | H-CAD | HCAD | L-CAD | LCAD | NAG22 | caldesmon 1 | | | 7q33 |
10280 | SIGMAR1 | ALS16 | DSMA2 | OPRS1 | SIG-1R | SR-BP | SR-BP1 | SRBP | hSigmaR1 | sigma1R | sigma non-opioid intracellular receptor 1 | | | 9p13.3 |
9536 | PTGES | MGST-IV | MGST1-L1 | MGST1L1 | MPGES | PGES | PIG12 | PP102 | PP1294 | TP53I12 | mPGES-1 | prostaglandin E synthase | | | 9q34.3 |